Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein.

It has previously been shown that human granulocyte-macrophage colony-stimulating factor (GM-CSF) can be fused to a truncated diphtheria toxin (DT) to produce a recombinant fusion toxin that kills GM-CSF receptor-bearing cells. We now report that DT388-GM-CSF induces apoptosis and inhibition of colony formation in semisolid medium in receptor positive cells, and that the induction of apoptosis correlates with GM-CSF-receptor occupancy at low ligand concentrations. Also, the induction of apoptosis correlates with the inhibition of protein synthesis and is inversely related to the amount of intracellular antiapoptotic proteins (Bcl2 and Bc1XL). Nine myeloid leukemia cells lines and four nonmyeloid leukemia cell lines were incubated with 0.7 nmol/L of 125I-GM-CSF in the presence or absence of excess cold GM-CSF and bound label measured. High affinity receptor numbers varied from 0 to 291 molecules per cell. Cells were incubated with varying concentrations of recombinant fusion toxin for 48 hours and incorporation of 3H-leucine (protein synthesis), segmentation of nuclei after DAPI staining (apoptosis), and colony formation in 0.2% agarose (clonogenicity) were measured. DT388-GM-CSF at 4 x 10(-9) mol/L inhibited colony formation 1.5 to 3.0 logs for receptor positive cell lines. Protein synthesis and apoptosis IC50s varied among cell lines from greater than 4 x 10(-9) mol/L to 3 x 10(-13) mol/L. GM-CSF-receptor occupancy at 0.7 nmol/L GM-CSF-ligand concentration correlated with the protein synthesis IC50. Similarly, the protein synthesis inhibition and apoptosis induction correlated well, except in cells overexpressing Bcl2 and BclXL, in which 25- to 150-fold inhibition of apoptosis was observed. We conclude that DT388-GM-CSF can kill acute myeloid leukemia blasts but that apoptotic sensitivities will depend on the presence of at least 100 high affinity GM-CSF receptors/cell and the absence of overexpressed antiapoptotic proteins.

[1]  J. Perentesis,et al.  Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  K. Bhalla,et al.  Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[3]  W. Wilmanns,et al.  Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. , 1996, Leukemia.

[4]  M. Willingham,et al.  Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells. , 1996, Cancer research.

[5]  K. Tew,et al.  Glutathione and related enzymes in multidrug resistance. , 1996, European journal of cancer.

[6]  A. List,et al.  Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. , 1996, Leukemia.

[7]  M. Cohen,et al.  Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. , 1996, Anticancer research.

[8]  K. Arai,et al.  Differential expression of granulocyte-macrophage colony-stimulating factor and IL-3 receptor subunits on human CD34+ cells and leukemic cell lines. , 1995, The Journal of allergy and clinical immunology.

[9]  P. Bamborough,et al.  Molecular modeling of the GM‐CSF and IL‐3 receptor complexes , 1995, Protein science : a publication of the Protein Society.

[10]  W. Balch,et al.  Ricin Cytotoxicity Is Sensitive to Recycling between the Endoplasmic Reticulum and the Golgi Complex (*) , 1995, The Journal of Biological Chemistry.

[11]  K. Klimpel,et al.  Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases , 1995, Infection and immunity.

[12]  P. Johnson,et al.  Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. , 1994, Oncogene.

[13]  S. Proctor,et al.  The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemia , 1994, British journal of haematology.

[14]  A. Dunn,et al.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  David L. Vaux,et al.  An evolutionary perspective on apoptosis , 1994, Cell.

[16]  A. Miyajima,et al.  Critical cytoplasmic domains of the common beta subunit of the human GM‐CSF, IL‐3 and IL‐5 receptors for growth signal transduction and tyrosine phosphorylation. , 1992, The EMBO journal.

[17]  M. Hallek,et al.  Interferon-gamma increases the expression of the gene encoding the beta subunit of the granulocyte-macrophage colony-stimulating factor receptor. , 1992, Blood.

[18]  D. Russell,et al.  Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor , 1992, Cell.

[19]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[20]  C. Bugg,et al.  Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. , 1992, Journal of molecular biology.

[21]  M. Belvin,et al.  Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells. , 1991, Blood.

[22]  O. Haas,et al.  MDR1 gene expression and treatment outcome in acute myeloid leukemia. , 1991, Journal of the National Cancer Institute.

[23]  S. Cannistra,et al.  Identification of functionally distinct domains of human granulocyte- macrophage colony-stimulating factor using monoclonal antibodies , 1991 .

[24]  T. Waldmann,et al.  The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Haman,et al.  IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation. , 1990, Leukemia.

[26]  K. Miyazono,et al.  Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.

[27]  A. Gazdar,et al.  Nonhematopoietic tumor cells express functional GM-CSF receptors , 1989 .

[28]  P. Casellas,et al.  An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin , 1989, International journal of cancer.

[29]  K. Kaushansky,et al.  Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Demetri,et al.  In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells. , 1988, Experimental hematology.

[31]  M. Minden,et al.  Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia. , 1988, Leukemia.

[32]  E. Vellenga,et al.  Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. , 1987, Leukemia.

[33]  P. Nowell,et al.  Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines , 1987 .

[34]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[35]  K. Tada,et al.  Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. , 1982, Cancer research.

[36]  C. Lozzio,et al.  A Multipotential Leukemia Cell Line (K-562) of Human Origin 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  J. Howard,et al.  ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. , 1980, The Journal of biological chemistry.

[38]  H. Koeffler,et al.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. , 1978, Science.

[39]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[40]  S Farber,et al.  Morphologic variations in human leukemic lymphoblasts (CCRF‐CEM cells) after long‐term culture and exposure to chemotherapeutic agents: A study with the electron microscope , 1966, Cancer.

[41]  H. Eagle,et al.  Propagation in a Fluid Medium of a Human Epidermoid Carcinoma, Strain KB , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[42]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[43]  J. Rasko,et al.  Cytokine receptor expression on hematopoietic stem and progenitor cells. , 1997, Blood.

[44]  J. Reed,et al.  Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein. , 1996, Leukemia.

[45]  D. Scheinberg,et al.  Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice. , 1996, Leukemia.

[46]  B. G. Sanders,et al.  RRR‐α‐tocopheryl succinate induces apoptosis in avian retrovirus‐transformed lymphoid cells , 1996 .

[47]  K. Cowan,et al.  Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. , 1995, Blood.

[48]  T. Strom,et al.  Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules. , 1994, Advances in nephrology from the Necker Hospital.

[49]  R. Salgia,et al.  Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. , 1994, Experimental hematology.

[50]  G. Demetri,et al.  The biology of GM-CSF: regulation of production and interaction with its receptor. , 1990, International journal of cell cloning.

[51]  E. Freireich,et al.  HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. , 1988, Blood.

[52]  J. Murphy The diphtheria toxin structural gene. , 1985, Current topics in microbiology and immunology.